Lead Product(s) : Apricoxib,Stimulon
Therapeutic Area : Oncology
Study Phase : Undisclosed
Sponsor : Agenus
Deal Size : Undisclosed
Deal Type : Collaboration
Details : Under the collaboration with Targovax, Agenus will supply QS-21 STIMULON and scientific support for up to three initial TG01 clinical trials in different cancer indications.
Brand Name : TG01
Molecule Type : Vaccine
Upfront Cash : Undisclosed
March 07, 2022
Lead Product(s) : Apricoxib,Stimulon
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Sponsor : Agenus
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?